🇺🇸 FDA
Patent

US 11510904

Methods of treating malignant lymphoproliferative disorders

granted A61KA61K31/407A61K31/433

Quick answer

US patent 11510904 (Methods of treating malignant lymphoproliferative disorders) held by ACTUATE THERAPEUTICS INC. expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACTUATE THERAPEUTICS INC.
Grant date
Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/407, A61K31/433, A61K31/52, A61K31/53